Sanara MedTech Inc.
HealthcareNASDAQ:SMTI · NASDAQ Capital Market
-$0.69 today
Vol 0.05M · Avg 0.05M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $13.6M |
| Receivables | $13.6M |
| Inventory | $3.1M |
| Other Current | $865.3K |
| Total Current Assets | $31.2M |
| PP&E (Net) | $2.5M |
| Goodwill | $3.6M |
| Intangible Assets | $17.9M |
| Long-term Investments | $14.2M |
| Total Non-current Assets | $38.1M |
| Total Assets | $69.3M |
Analysis
Selected assets total $69.3M for Latest. The largest visible component is Intangible Assets at $17.9M, about 25.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16.6M +4.4% | $15.9M +208.5% | $5.1M -42.5% | $9.0M -52.0% | $18.7M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $12.0M -11.5% | $13.6M +58.8% | $8.5M +21.8% | $7.0M +134.2% | $3.0M | $533.8M | $399.4M | -$1.7B |
| Inventory | $3.9M +43.4% | $2.8M -41.6% | $4.7M +32.9% | $3.5M +73.3% | $2.0M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $1.0M -9.5% | $1.1M +84.7% | $608.4K -44.9% | $1.1M | $0 | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $33.5M +0.7% | $33.3M +75.2% | $19.0M -7.8% | $20.6M -16.2% | $24.6M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $2.5M +34.7% | $1.9M -42.2% | $3.3M +46.4% | $2.2M +8.8% | $2.0M | $1.2B | $1.5B | $687.8M |
| Goodwill | $3.6M +0.0% | $3.6M +0.0% | $3.6M +0.0% | $3.6M | $0 | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $18.6M -54.5% | $41.0M -8.7% | $44.9M +42.6% | $31.5M +566.5% | $4.7M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $14.6M +76.3% | $8.3M +169.0% | $3.1M +0.0% | $3.1M -38.5% | $5.0M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $0 | $0 | $0 | $0 | $0 | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $39.4M -28.1% | $54.8M -0.1% | $54.9M +35.7% | $40.4M +242.9% | $11.8M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $72.9M -17.2% | $88.1M +19.3% | $73.9M +21.0% | $61.0M +67.7% | $36.4M | $13.3B | $11.9B | $10.6B |
| Account Payables | $2.3M +55.9% | $1.5M -25.1% | $2.0M +40.3% | $1.4M +140.2% | $594.0K | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $353.2K | $0 -100.0% | $580.4K | $0 | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $1.2M | $0 -100.0% | $2.0M | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $235.0K | $0 +100.0% | -$947.7K -181.5% | $1.2M | $0 | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $18.6M +21.8% | $15.3M +11.1% | $13.8M +7.5% | $12.8M +112.6% | $6.0M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $46.0M +49.8% | $30.7M +236.8% | $9.1M | $0 | $0 | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $548.1K -72.1% | $2.0M -57.9% | $4.7M -22.3% | $6.0M | $0 | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $48.4M +42.8% | $33.9M +118.4% | $15.5M +138.4% | $6.5M +2830.0% | $222.2K | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $67.0M +36.3% | $49.2M +67.9% | $29.3M +51.6% | $19.3M +209.3% | $6.2M | $14.7B | $3.7B | $9.6B |
| Common Stock | $8.9K +2.2% | $8.8K +2.6% | $8.5K +2.8% | $8.3K +8.1% | $7.7K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$75.3M -99.3% | -$37.8M -34.8% | -$28.0M -19.8% | -$23.4M -53.6% | -$15.2M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | -$8.7K | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | -$8.7K +98.2% | -$491.6K -101.3% | -$244.3K -127.1% | -$107.6K +78.0% | -$488.4K | $1.4B | $337.8M | $931.4M |
| Total Equity | $5.9M -84.8% | $38.9M -12.7% | $44.6M +6.9% | $41.7M +38.4% | $30.2M | $9.1B | $7.7B | $3.3B |
| Total Debt | $48.2M +49.3% | $32.3M +173.8% | $11.8M +1339.4% | $819.2K +92.6% | $425.4K | $724.2M | $410.6M | $399.4M |
| Net Debt | $31.6M +92.7% | $16.4M +146.9% | $6.6M +181.6% | -$8.1M +55.3% | -$18.2M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Viemed Healthcare, Inc.
NASDAQ:VMD
$400.62M
TruBridge, Inc.
NASDAQ:TBRG
$391.78M
NeoGenomics, Inc.
NASDAQ:NEO
$290.37M
Sight Sciences, Inc.
NASDAQ:SGHT
$279.12M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$250.78M
LifeMD, Inc.
NASDAQ:LFMD
$227.30M
Owens & Minor, Inc.
OMI
$207.07M
High Tide Inc.
NASDAQ:HITI
$203.04M
Stereotaxis, Inc.
AMEX:STXS
$179.84M
Exagen Inc.
NASDAQ:XGN
$112.83M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does SMTI have?
Sanara MedTech Inc. (SMTI) reported $16.58M in cash and equivalents in fiscal 2025.
How much debt does SMTI carry?
Sanara MedTech Inc. (SMTI) reported $48.19M of total debt, with net debt of $31.61M.
Explore More
Continue the stock analysis
Jump to another research area for this company.